tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Astrazeneca Plc (AZN)
NASDAQ:AZN
US Market
AZN
AstraZeneca
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

AstraZeneca (AZN) Stock News & Sentiment

Compare
7,344 Followers
Technical Analysis Says These 3 Stocks Are Ready to Rally
Premium
Market News
Technical Analysis Says These 3 Stocks Are Ready to Rally
9h ago
C
AZN
AstraZeneca’s AZD2389 Phase I Study Completion: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s AZD2389 Phase I Study Completion: Key Insights for Investors
1d ago
AZN
AstraZeneca’s PROVIDENCE Study: Real-world Insights into Trastuzumab Deruxtecan for Metastatic Breast Cancer
Premium
Company Announcements
AstraZeneca’s PROVIDENCE Study: Real-world Insights into Trastuzumab Deruxtecan for Metastatic Breast Cancer
3d ago
AZN
AstraZeneca’s Promising Phase II Study on AZD0901 for Advanced Solid Tumors
Premium
Company Announcements
AstraZeneca’s Promising Phase II Study on AZD0901 for Advanced Solid Tumors
3d ago
AZN
AstraZeneca’s Latest Phase 4 Study: A Boost for HER2-Positive Breast Cancer Treatment?
Premium
Company Announcements
AstraZeneca’s Latest Phase 4 Study: A Boost for HER2-Positive Breast Cancer Treatment?
3d ago
AZN
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
Premium
Company Announcements
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
3d ago
AZN
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
Premium
Company Announcements
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
3d ago
AZN
ABBV
More AZN News >

AZN News on the Web

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum
Zacks
Neutral
Technical Analysis Says These 3 Stocks Are Ready to Rally
TipRanks News
Neutral
Johnson & Johnson JNJ Stock vs AstraZeneca AZN Stock – Growth or Dividend Reliability?
TradingNEWS.com
Bullish
AstraZeneca Stock Price Forecast - AZN at $81.28 Price, Strong Pipeline and 20% Upside
TradingNEWS.com
Bullish
Johnson & Johnson Stock Forecast - JNJ at $177 Eyes $187 as Dividend Power Meets Solid EPS
TradingNEWS.com
Neutral
LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal
Zacks
Neutral
Will LLY's Oncology Portfolio Provide Key Diversification Benefits?
Zacks
Neutral
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Zacks
Neutral

News Score - Last 7 Days

Positive
AZN
Sector Average
Media Buzz
This Week21 articles
Weekly Average15 articles
News Sentiment
This Week100%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AZN’s Media Buzz Sentiment?
21 articles about AZN were published this week. In an average week, 15 articles are published.
    What is AZN’s weekly average amount of articles?
    In an average week, 15 articles about AZN are published.
      What is AZN’s News Sentiment?
      100% of articles about AZN were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        PHRPhreesia
        IMVTImmunovant
        DMACDiamedica Therapeutics
        RAREUltragenyx Pharmaceutical
        SMMTSummit Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing